Post-marketing observational study on the efficacy and safety of Neuroguidewire for the treatment of istroke and aneurysm

Post-marketing observational study on the efficacy and safety of Neuroguidewire for the treatment of istroke and aneurysm - C-AISIA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1032240362

Enrollment

Registered

2024-10-03

Start date

2023-09-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke and brain aneurysm Ischemic Stroke, AIS, stroke, Intracranial Aneurysm

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients who have undergone endovascular treatment using a CHIKAI neuroguidewire for stroke or aneurysm during the investigations period. 2) Patients who have given consent for the use of their medical information.

Exclusion criteria

Exclusion criteria: 1.Patients treated with unapproved medical devices.

Design outcomes

Primary

Measure	Time frame
Efficacy Success rate of microcatheter guidance	—

Secondary

Measure	Time frame
Efficacy 1) Reach of the research device (guidewire) to the target site 2) Need for replacement with other neuroguidewire 3) Microcatheter or balloon catheter used in combination (product name) Safety 1) Failure during the procedure related to the research device 2) Whether or not there are any adverse events that cannot be ruled out as causally related to the research device.	—

Contacts

Public ContactMasafumi Morimoto

Yokohamashintoshi Neurosurgical Hospital

investigationclinical.001@gmail.com+81-45-911-2011

Outcome results